Shuttle Pharmaceuticals Holdings (SHPH) Total Debt (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Debt history runs 5 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• On a quarterly basis, Total Debt changed N/A year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.4 million, changed N/A from the prior year.
• Total Debt held at $4.4 million in Q1 2026 per SHPH's latest filing, from $4.4 million in the prior quarter.
• Across five years, Total Debt topped out at $4.4 million in Q4 2025 and bottomed at $73007.0 in Q3 2022.
• The 4-year median for Total Debt is $139229.0 (2023), against an average of $1.8 million.
• Biggest YoY gain for Total Debt was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• Year by year, Total Debt stood at $73007.0 in 2022, then soared by 90.71% to $139229.0 in 2023, then jumped by 3086.07% to $4.4 million in 2025, then changed by 0.0% to $4.4 million in 2026.
• Per Business Quant, the three latest SHPH Total Debt figures stand at $4.4 million (Q1 2026), $4.4 million (Q4 2025), and $139229.0 (Q1 2023).